查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1268900

2023-2030 年按类型（实心、空心）、材料（硅、金属）、应用（皮肤科、药物输送）、地区、细分趋势分列的微针给药系统市场规模、份额、趋势分析报告

Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Solid, Hollow), By Material (Silicon, Metal), By Application (Dermatology, Drug Delivery), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

微针给药系统市场增长和趋势：

根据 Grand View Research, Inc. 的最新报告，全球微针给药系统市场规模从 2023 年到 2030 年的复合年增长率将达到 7.4%，到 2030 年将达到 94%。预计将达到6000万美元。

对传统皮下注射更安全替代品的需求不断增加，以及对微创和无痛给药意识的增强，预计将推动微针给药系统的市场增长。 此外，糖尿病患者数量的增加也有望推动市场增长。 例如，据世界卫生组织 (WHO) 估计，到 2021 年，全球约有 4.63 亿成年人患有糖尿病，占世界人口的 9.3%。

与口服和经皮途径等传统给药方法相比，微针具有多项优势。 研究表明，微针给药可以提高药物的吸收、生物利用度和药效，尤其是对于低水溶性或低渗透性的药物。 例如，发表在《Journal of Controlled Release》上的一项研究表明，使用微针透皮注射胰岛素比皮下注射更有效。

COVID-19 大流行对微针给药产生了重大影响。 大流行对市场的一个主要影响是对疫苗交付的需求增加。 微针因其易用性、低成本和可能引发强烈免疫反应而被认为是 COVID-19 疫苗的候选递送方法。 大流行加速了基于微针的疫苗输送系统的开发，多家公司和学术机构致力于开发 COVID-19 疫苗贴剂。

但是，大流行正在扰乱全球供应链并影响微针给药系统的生产和分销。 一些製造商难以获得原材料和零部件，导致供应短缺和价格上涨。

微针给药系统市场报告要点：

  • 空心微针细分市场在 2022 年占据了最大的收入份额，因为它最适合用于疫苗和激素治疗患者。
  • 预计可溶性微针部分在预测期内将以最快的速度增长，因为微针插入后无需取出，只需一个步骤。
  • 到 2022 年，金属材料领域的收入份额将最高，其中不銹钢和钛是最常用的金属。
  • 按应用来看，药物输送领域在 2022 年占据了市场主导地位。
  • 由于人们对疫苗接种的认识不断提高，预计疫苗部分在预测期内将呈现最快的增长速度。
  • 由于中国和印度等新兴经济体存在未开发的机会，预计亚太地区在预测期内将以最快的复合年增长率增长。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 类型
    • 材料
    • 申请
    • 区域范围
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
      • 北美的首次采访数据
      • 欧洲主要访谈数据
      • 来自亚太地区主要访谈的数据
      • 拉丁美洲主要访谈数据
      • MEA 主要访谈数据
  • 信息或数据分析
    • 数据分析模型
  • 市场形成和验证
  • 模型详细信息
    • 产品流分析（模型 1）
    • 方法 1：产品流方法
    • 批量价格分析（模型 2）
    • 方法 2：量价分析
  • 次要信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场前景
  • 细分市场展望
    • 类型展望
    • 材料展望
    • 使用前景
    • 区域展望
  • 竞争考虑

第 3 章微针给药系统市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场展望
    • 相关/补充市场展望
  • 采用和增长前景映射
  • 行业价值链分析
    • 报销框架
  • 市场动态
    • 市场驱动因素分析
      • 对传统皮下注射的更安全替代品的需求不断增加
      • 糖尿病患者在世界范围内不断增加
      • 技术进步
    • 市场製约因素分析
      • 批准的产品数量有限
      • 与微针相关的并发症/风险
  • 微针给药系统市场分析工具
    • 行业分析 - 搬运工
      • 供应商的力量
      • 买家的议价能力
      • 更换威胁
      • 新进入者的威胁
      • 竞争公司之间的敌对关係
    • PESTEL 分析
      • 政治形势
      • 技术情况
      • 经济状况
    • 对主要交易和战略联盟的分析
    • 市场进入策略

第 4 章微针给药系统：类型估计和趋势分析

  • 定义和范围
    • 固体
    • 中空
    • 溶解
    • 涂层
    • 其他
  • 类型市场份额，2022 年和 2030 年
  • 部门仪表板
  • 按类型分列的全球微针给药系统市场前景
  • 以下市场规模、预测和趋势分析，2018-2030 年
    • 固体
    • 中空
    • 溶解
    • 涂层
    • 其他

第 5 章微针给药系统：材料估算和趋势分析

  • 材料和范围
    • 硅
    • 金属
    • 聚合物
    • 其他
  • 材料市场份额，2022 年和 2030 年
  • 部门仪表板
  • 按材料分列的全球微针给药系统市场前景
  • 以下市场规模、预测和趋势分析，2018-2030 年
    • 硅
    • 金属
    • 聚合物
    • 其他

第 6 章微针给药系统：应用估算和趋势分析

  • 定义和范围
    • 皮肤科
    • 给药
    • 疼痛管理
    • 癌症治疗
    • 提供疫苗
    • 其他
  • 2022 年和 2030 年的应用市场份额
  • 部门仪表板
  • 按应用划分的全球微针给药系统市场展望
  • 以下市场规模、预测和趋势分析，2018-2030 年
    • 皮肤科
    • 荷尔蒙输送
    • 疼痛管理
    • 癌症治疗
    • 提供疫苗
    • 其他

第 7 章微针给药系统市场：区域估计和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2021 年区域市场份额和主要参与者
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • SWOT 因素分析（政治/法律、经济/技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场规模、预测、数量和趋势分析
  • 北美
    • 2018-2030 年市场估计和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 沙特阿拉伯
    • 南非
    • 阿拉伯联合酋长国
    • 科威特

第八章竞争格局

  • 主要市场进入者的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要分销商和渠道合作伙伴名单
    • 主要客户
    • 2021 年主要公司市场份额分析
    • Raphas
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Novartis International AG
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Becton, Dickinson and Company
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • B. Braun
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Nanopass technologies limited
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Termo
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Smiths Medical
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Cardinal Health
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 3M
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-555-9

Microneedle Drug Delivery Systems Market Growth & Trends:

The global microneedle drug delivery systems market size is expected to reach USD 9.46 billion by 2030, registering a CAGR of 7.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing demand for safer alternatives to conventional hypodermic injection and increasing awareness about minimally invasive and pain-free administration of drugs is expected to boost the market growth for microneedle drug delivery systems. Furthermore, increasing cases of diabetes are also expected to boost the market growth. For instance, as per the estimates of the World Health Organization (WHO) in 2021, approximately 463 million adults were living with diabetes, worldwide, representing 9.3% of the global population.

Microneedles offer several advantages over traditional drug delivery methods, such as oral or transdermal routes. Studies have shown that drug delivery by microneedles can improve drug absorption, bioavailability and efficacy, especially for drugs with poor water solubility or low permeability. For instance, a study published in "Journal of Controlled Release" showed that transdermal delivery of insulin using microneedles was more effective than subcutaneous injection.

The COVID-19 pandemic had a significant impact on drug delivery by microneedles. The major impact of the pandemic on the market was the increased demand for vaccine delivery. Microneedles have been explored as a potential delivery method for the COVID-19 vaccines due to their ease of use, low cost, and potential to induce a strong immune response. The pandemic has accelerated development of the microneedle-based vaccine delivery systems, with several companies and academic institutions working on COVID-19 vaccine patches.

However, the pandemic has also disrupted global supply chains, which has affected the production and distribution of microneedle-based drug delivery systems. Some manufacturers have faced challenges in obtaining raw materials and components, which has resulted in supply shortages and increased prices.

Microneedle Drug Delivery Systems Market Report Highlights:

  • The hollow microneedle segment accounted for the largest revenue share in 2022, since they are considered ideal for the use of vaccine and hormonal therapy patients
  • Dissolving microneedle segment is expected to grow at the fastest rate during the forecast period, as it only requires one step, the microneedle needs not be removed after insertion
  • The metal material segment accounted for the highest revenue share in 2022; stainless steel and titanium are the most frequently employed metals
  • By application, drug delivery segment dominated the market in 2022
  • The vaccine segment is expected to experience the fastest growth rate during the forecast period due to the increased awareness of vaccination among populations
  • Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Material
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing demand for safer substitute to conventional hypodermic injections
      • 3.4.1.2. Increase in diabetic cases across the globe
      • 3.4.1.3. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited number of approved products
      • 3.4.2.2. Complications/risks associated with microneedles
  • 3.5. Microneedle Drug Delivery Systems Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Microneedle Drug Delivery Systems : Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Solid
    • 4.1.2. Hollow
    • 4.1.3. Dissolving
    • 4.1.4. Coated
    • 4.1.5. Others
  • 4.2. Type Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Solid
      • 4.5.1.1. Solid market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Hollow
      • 4.5.2.1. Hollow market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Dissolving
      • 4.5.3.1. Dissolving market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Coated
      • 4.5.4.1. Coated market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Microneedle Drug Delivery Systems : Material Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Silicon
    • 5.1.2. Metal
    • 5.1.3. Polymer
    • 5.1.4. Others
  • 5.2. Material Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Silicon
      • 5.5.1.1. Silicon market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Metal
      • 5.5.2.1. Metal market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Polymer
      • 5.5.3.1. Polymer market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Microneedle Drug Delivery Systems : Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Dermatology
    • 6.1.2. Drug delivery
    • 6.1.3. Pain management
    • 6.1.4. Cancer therapy
    • 6.1.5. Vaccine delivery
    • 6.1.6. Others
  • 6.2. Application Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
    • 6.5.1. Dermatology
      • 6.5.1.1. Dermatology market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Hormone delivery
      • 6.5.2.1. Hormone delivery market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Pain management
      • 6.5.3.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer therapy
      • 6.5.4.1. Cancer therapy market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Vaccine delivery
      • 6.5.5.1. Vaccine delivery market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Others
      • 6.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2021
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8. Europe
    • 7.8.1. UK
      • 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. Germany
      • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. France
      • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. Italy
      • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Spain
      • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.6. Sweden
      • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.7. Norway
      • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.8. Denmark
      • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. China
      • 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 7.9.3. India
      • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.4. Australia
      • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.5. Thailand
      • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.6. South Korea
      • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.10. Latin America
    • 7.10.1. Brazil
      • 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.2. Mexico
      • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.3. Argentina
      • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11. MEA
    • 7.11.1. Saudi Arabia
      • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2021
    • 8.3.4. Raphas
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Novartis International AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Becton, Dickinson and Company
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. B. Braun
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Nanopass technologies limited
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Termo
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Smiths Medical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Cardinal Health
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. 3M
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Abbreviation
  • Table 3 North America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 5 North America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 9 U.S. microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 12 Canada microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 15 Europe microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 17 Germany microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 19 Germany microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 22 UK microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 23 France microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 24 France microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 25 France microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 28 Italy microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 31 Spain microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 32 Sweden microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 33 Sweden microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 34 Sweden microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 35 Norway microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 37 Norway microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 40 Denmark microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 41 APAC microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 42 APAC microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 43 APAC microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 44 APAC microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 45 China microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 46 China microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 47 China microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 48 Japan microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 50 Japan microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 51 India microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 52 India microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 53 India microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 54 Thailand microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 55 Thailand microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 56 Thailand microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 57 South Korea microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 59 South Korea microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 60 Latin America microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 61 Latin America microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 62 Latin America microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 63 Latin America microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 64 Brazil microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 66 Brazil microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 67 Mexico microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 68 Mexico microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 69 Mexico microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 70 Argentina microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 71 Argentina microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 72 Argentina microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa microneedle drug delivery systems market, by region, 2018 - 2030 (USD Million)
  • Table 77 South Africa microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Africa microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 79 South Africa microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 83 UAE microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 84 UAE microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 85 UAE microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)
  • Table 86 Kuwait microneedle drug delivery systems market, by type, 2018 - 2030 (USD Million)
  • Table 87 Kuwait microneedle drug delivery systems market, by material, 2018 - 2030 (USD Million)
  • Table 88 Kuwait microneedle drug delivery systems market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle Drug Delivery Systems : market outlook
  • Fig. 9 Microneedle Drug Delivery Systems competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Microneedle drug delivery systems market driver impact
  • Fig. 15 Microneedle drug delivery systems market restraint impact
  • Fig. 16 Microneedle drug delivery systems market strategic initiatives analysis
  • Fig. 17 Microneedle drug delivery systems market: type movement analysis
  • Fig. 18 Microneedle drug delivery systems market: type outlook and key takeaways
  • Fig. 19 Solid market estimates and forecast, 2018 - 2030
  • Fig. 20 Hollow market estimates and forecast, 2018 - 2030
  • Fig. 21 Dissolving market estimates and forecast, 2018 - 2030
  • Fig. 22 Coated market estimates and forecast, 2018 - 2030
  • Fig. 23 Others market estimates and forecast, 2018 - 2030
  • Fig. 24 Microneedle drug delivery systems market: material movement analysis
  • Fig. 25 Microneedle drug delivery systems market: material outlook and key takeaways
  • Fig. 26 Silicon market estimates and forecast, 2018 - 2030
  • Fig. 27 Metal market estimates and forecast, 2018 - 2030
  • Fig. 28 Polymer market estimates and forecast, 2018 - 2030
  • Fig. 29 Others market estimates and forecast, 2018 - 2030
  • Fig. 30 Microneedle drug delivery systems market: application movement analysis
  • Fig. 31 Microneedle drug delivery systems market: application outlook and key takeaways
  • Fig. 32 Dermatology market estimates and forecast, 2018 - 2030
  • Fig. 33 Drug delivery market estimates and forecast, 2018 - 2030
  • Fig. 34 Pain management market estimates and forecast, 2018 - 2030
  • Fig. 35 Cancer therapy market estimates and forecast, 2018 - 2030
  • Fig. 36 Vaccine delivery market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Global microneedle drug delivery systems market: regional movement analysis
  • Fig. 39 Global microneedle drug delivery systems market: regional outlook and key takeaways
  • Fig. 40 Global market share and leading players
  • Fig. 41 North America market share and leading players
  • Fig. 42 Europe market share and leading players
  • Fig. 43 Asia Pacific market share and leading players
  • Fig. 44 Latin America market share and leading players
  • Fig. 45 Middle East & Africa market share and leading players
  • Fig. 46 North America: SWOT
  • Fig. 47 Europe SWOT
  • Fig. 48 Asia Pacific SWOT
  • Fig. 49 Latin America SWOT
  • Fig. 50 MEA SWOT
  • Fig. 51 North America, by country
  • Fig. 52 North America
  • Fig. 53 North America market estimates and forecast, 2018 - 2030
  • Fig. 54 U.S.
  • Fig. 55 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 56 Canada
  • Fig. 57 Canada market estimates and forecast, 2018 - 2030
  • Fig. 58 Europe
  • Fig. 59 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 60 UK
  • Fig. 61 UK market estimates and forecast, 2018 - 2030
  • Fig. 62 Germany
  • Fig. 63 Germany market estimates and forecast, 2018 - 2030
  • Fig. 64 France
  • Fig. 65 France market estimates and forecast, 2018 - 2030
  • Fig. 66 Italy
  • Fig. 67 Italy market estimates and forecast, 2018 - 2030
  • Fig. 68 Spain
  • Fig. 69 Spain market estimates and forecast, 2018 - 2030
  • Fig. 70 Sweden
  • Fig. 71 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 72 Norway
  • Fig. 73 Norway market estimates and forecast, 2018 - 2030
  • Fig. 74 Denmark
  • Fig. 75 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 76 Asia Pacific
  • Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 78 China
  • Fig. 79 China market estimates and forecast, 2018 - 2030
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecast, 2018 - 2030
  • Fig. 82 India
  • Fig. 83 India market estimates and forecast, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2018 - 2030
  • Fig. 86 Thailand
  • Fig. 87 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 88 South Korea
  • Fig. 89 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 90 Latin America
  • Fig. 91 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 92 Brazil
  • Fig. 93 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 94 Mexico
  • Fig. 95 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 96 Argentina
  • Fig. 97 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 98 Middle East and Africa
  • Fig. 99 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 100 Saudi Arabia
  • Fig. 101 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 UAE
  • Fig. 105 UAE market estimates and forecast, 2018 - 2030
  • Fig. 106 Kuwait
  • Fig. 107 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 108 Participant categorization - Microneedle Drug Delivery Systems market
  • Fig. 109 Market share of key market players - Microneedle drug delivery systems market